Jay Giri, MD MPH is the director of peripheral intervention at the University of Pennsylvania, the director of the cardiovascular catheterization laboratory at the Philadelphia Veterans Affairs Medical Center, and the associate director of the Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center. His clinical interests include complex coronary artery disease, venous thromboembolism, and aortic valve disease. He performs clinical outcomes and comparative effectiveness research related to emerging endovascular technologies and interventional pharmacotherapies as well as health policy research related to cardiovascular medicine. Contributions Jay Giri, MD, MPH, FSCAI SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Best Practices for Optimal Techniques, Competence, Training, and Organizational Recommendations Jay Giri, MD, MPH, FSCAI SCAI Publications Manual of Standard Operating Procedures—2022 Update Jay Giri, MD, MPH, FSCAI North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) Registry: Rationale, Design, and Implications Jay Giri, MD, MPH, FSCAI Pulmonary Artery Stenting as a Treatment for Severe Stenosis Caused by Fibrosing Mediastinitis Jay Giri, MD, MPH, FSCAI Initial Findings From the North American COVID-19 Myocardial Infarction Registry Jay Giri, MD, MPH, FSCAI How To Perform an Invasive Pulmonary Angiogram in Chronic Thrombo-Embolism Pulmonary Disease Work Up Jay Giri, MD, MPH, FSCAI Balloon Pulmonary Angioplasty in Distal CTEPH Jay Giri, MD, MPH, FSCAI Considerations for Cardiac Catheterization Laboratory Procedures During the COVID‐19 Pandemic Jay Giri, MD, MPH, FSCAI What Should the Role of the Surgeon Be in TAVR, Both as a Co-Operator and in-Patient Evaluation for TAVR?
